Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer

Different pathological response and histological features following neoadjuvant chemotherapy or chemo-immunotherapy in resected non-small cell lung cancer

IntroductionNon-small cell lung cancer (NSCLC) is the leading cause of cancer incidence and mortality worldwide. Neoadjuvant chemo-immunotherapy has led to clinical benefits in resectable NSCLC in comparison to chemo-therapy alone. Major pathological response (MPR) and pathological complete response...

Full description

Bibliographic Details
Main Authors: Greta Alì, Anello Marcello Poma, Iosè Di Stefano, Carmelina Cristina Zirafa, Alessandra Lenzini, Giulia Martinelli, Gaetano Romano, Antonio Chella, Editta Baldini, Franca Melfi, Gabriella Fontanini
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-02-01
Series:Frontiers in Oncology
Subjects:
non-small cell lung cancer
neoadjuvant therapy
chemo-immunotherapy
pathological response
prognosis
biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1115156/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2023.1115156/full

Similar Items